MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202411013142 A) filed by University Of Georgia Research Foundation, Inc.; and Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Athens, U.S.A., on Feb. 23, 2024, for 'pentavalent influenza virus immunogens, compositions and methods of use thereof.'
Inventor(s) include Ted M. Ross; James D. Allen; Naoko Uno; and Carlos A. Guzman.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "Provided is a immunogenic pentavalent composition, vaccine, and formulations thereof, composed of five, isolated, non-naturally occurring, immunogenic antigens derived from influenza viruses that are capable of eliciting a broadly reactive immune response, e.g., a broadly reactive neutralizing antibody response directed against influenza virus antigens, following introduction into a subject. Also provided are immunogens and virus-like particles (VLPs) comprising the pentavalent composition. Methods of generating an immune response in a human or non-human subject by administering the pentavalent composition are provided. In particular, the pentavalent immunogen comprises isolated, broadly reactive hemagglutinin (HA) protein antigens of influenza virus strains, such as H1, H3, and IBV, and viral neuraminidase (NA) N1 and N2 protein antigens, which may be recombinant and/or recombinantly produced."
Disclaimer: Curated by HT Syndication.
